A detailed history of Financial Gravity Asset Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 7 shares of AMGN stock, worth $2,165. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 11 36.36%
Holding current value
$2,165
Previous $3.32 Million 41.14%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 26, 2024

SELL
$268.87 - $324.56 $1,075 - $1,298
-4 Reduced 36.36%
7 $1.96 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $8,066 - $9,736
-30 Reduced 46.15%
35 $9.72 Million
Q4 2023

Jun 26, 2024

SELL
$255.7 - $288.46 $6,136 - $6,923
-24 Reduced 68.57%
11 $3.32 Million
Q3 2023

Nov 15, 2023

SELL
$218.65 - $271.46 $34,984 - $43,433
-160 Reduced 71.11%
65 $17,000
Q2 2023

Aug 08, 2023

SELL
$214.27 - $253.37 $3,642 - $4,307
-17 Reduced 7.02%
225 $6.05 Million
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $4,741 - $5,779
-21 Reduced 7.98%
242 $4.2 Million
Q4 2022

Feb 15, 2023

SELL
$229.03 - $291.01 $1.49 Million - $1.89 Million
-6,487 Reduced 96.1%
263 $14.2 Million
Q3 2022

Nov 03, 2022

SELL
$224.46 - $253.15 $339,383 - $382,762
-1,512 Reduced 18.3%
6,750 $9.41 Million
Q2 2022

Aug 05, 2022

BUY
$230.71 - $256.74 $1.01 Million - $1.13 Million
4,386 Added 113.16%
8,262 $8.07 Million
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $136,824 - $151,363
-624 Reduced 13.87%
3,876 $2.03 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $886,408 - $1.01 Million
4,457 Added 10365.12%
4,500 $2.04 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $212 - $248
-1 Reduced 2.27%
43 $213,000
Q2 2021

Aug 11, 2021

SELL
$233.58 - $259.14 $1,635 - $1,813
-7 Reduced 13.73%
44 $244,000
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $1,775 - $2,068
-8 Reduced 13.56%
51 $12.6 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $12,766 - $15,202
59 New
59 $13,000
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $92,970 - $114,087
-470 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$182.24 - $241.7 $19,317 - $25,620
-106 Reduced 18.4%
470 $95,000
Q4 2019

Feb 28, 2020

SELL
$189.21 - $243.2 $49,005 - $62,988
-259 Reduced 31.02%
576 $251,000
Q3 2019

Oct 15, 2019

SELL
$174.11 - $208.62 $35,518 - $42,558
-204 Reduced 19.63%
835 $162,000
Q2 2019

Jul 26, 2019

SELL
$166.7 - $195.41 $36,840 - $43,185
-221 Reduced 17.54%
1,039 $191,000
Q1 2019

Apr 19, 2019

SELL
$180.87 - $203.88 $463,931 - $522,952
-2,565 Reduced 67.06%
1,260 $242,000
Q3 2018

Oct 31, 2018

BUY
$185.29 - $208.89 $60,589 - $68,307
327 Added 9.35%
3,825 $720,000
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $11,789 - $13,242
71 Added 2.07%
3,498 $680,000
Q1 2018

May 23, 2018

BUY
$169.43 - $198.0 $580,636 - $678,546
3,427 New
3,427 $579,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $165B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.